Varenicline for Cognitive Deficits and Cigarette Smoking in Schizophrenia - Efficacy and Predictors

NCT00802919 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

93

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Cigarette Smoking

Interventions

DRUG: Varenicline
DRUG: Placebo for varenicline

Sponsor

Nathan Kline Institute for Psychiatric Research